retatrutide dosing trials Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial What caught my attention wasn't

Supports bone health during rapid weight loss

Retatrutide starts at 2 mg and steps up to 4, 8, and 12 mg over roughly 16 weeks, at least on the Phase 2 schedule, since Phase 3 may shuffle that

With that said, Retatrutide clearly shows the best results

This is expected medication effect, not dangerous for most

Nevertheless, as the simultaneous activation of GLP-1 and GIP receptors in preclinical models results in greater WL and glucose-lowering efficacy compared to activation of each receptor alone [38,39,40], the interest for the development of unimolecular GLP-1 and GIP RA was increased, despite that this additive effect in food intake and glycaemia was not observed in some acute clinical studies [41, 42]

The world would be a much more pleasant place. And to peel back the curtain a bit, I was once nearly 500 pounds myself and now weigh 210